- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
|
|
|
254 |
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
Figure 19.3. cross-sectional |
|
|
|
anatomy of the oral mucosa. |
|
|
|
demonstrated is a buccal mucosa |
Buccal |
Oral epithelium |
|
with the layers of the buccal |
mucosa |
|
|
mucosal graft demonstrated. |
|
||
graft |
|
||
cross-section of anatomy of the |
|
Superficial lamina |
|
vascularity (bottom) (reprinted |
|
||
|
(submucosa) |
||
from Jordan and schlossberg17. |
|
||
|
|
||
contemporary Urology is a |
|
|
|
copyrighted publication of |
|
|
|
advanstar communications inc. |
|
Deep lamina |
|
all rights reserved). |
|
||
|
|
|
(submucosa) |
Muscle and minor salivary glands
over time. However, if the force remains constant, the tissue will continue to distend, and this property is termed creep.20
Grafts
Transfer of tissue can be performed via the use of grafts or flaps. A graft is tissue that has been excised and transferred to a graft host bed, where a new blood supply develops by a process termed take. This process is dependent on the bulk of the graft and the number of exposed
vessels on the undersurface of the graft as well as the surface of the bed. The initial phase of graft take, imbibition, lasts approximately 48 h. During that phase, the graft survives by “drinking” nutrients from the adjacent graft host bed. The temperature of the graft remains lower than core body temperature. The second phase, inosculation, also requires about 48 h. It is during this phase that true microcirculation is reestablished in the graft and the temperature of the graft rises to core body temperature. The process of take is influenced by both the nature of the grafted tissue and the conditions of the graft
255
WoUnd HEaling and PrinciPlEs of Plastic sUrgEry
STSG
Figure 19.4. demonstration of the viscoelastic properties: (Top) stress relaxation. a force is applied to the tissue, the distension remains constant,the force to maintain that distension decreases; (Bottom) creep. in this model, the force of distension remains constant, over time under that force, the tissue elongates.
host bed. Processes that disrupt or impair the vascularity of the graft host bed thus interfere with graft take.18
The epidermal or epithelial layer is a covering, acting as a barrier to the external environment. It lies adjacent to the superficial dermis or superficial lamina. At approximately that interface is the superficial plexus. This plexus is the intradermal plexus in skin. On the undersurface of the deep dermal layer or deep lamina lies the deep plexus. In skin, this is the subdermal plexus. The deep dermis contains most of the lymphatics and greater collagen content than in the superficial dermal layer. The deep or reticular dermis is generally thought to account for the physical characteristics of the tissue.19
A split thickness graft carries the epidermis, or the covering, and the superficial dermis. This graft exposes the superficial dermal (intradermal or intralaminar) plexus. In most grafts, the superficial plexus is composed of small but numerous vessels allowing for many possible graft-bed connections allowing favorable vascular characteristics. This unit has few lymphatics, and the reticular dermis (and its
Figure 19.5. demonstration of the cross-section of anatomy of the skin, with the layers of a split-thickness graft demonstrated (reprinted with permission from Jordan and schlossberg17. contemporary Urology is a copyrighted publication of advanstar communications inc. all rights reserved).
physical characteristics) are not carried, which accounts for the tendency of split-thickness units to be brittle and, in some cases, less durable (Fig. 19.5).
A full-thickness graft carries the covering, the superficial dermis or lamina and the deep dermis or lamina with all the characteristics attributable to that layer (Fig. 19.6). In skin, the subdermal plexus is exposed. In most cases, that subdermal plexus is composed of larger vessels that are more sparsely distributed (Fig. 19.7). The graft is thus fastidious in its vascular characteristics. A fullthickness unit carries most of the lymphatics, and these physical characteristics are carried with the transferred tissue. If we examine the grafts that are most commonly used in genitourinary reconstructive surgery, the split-thickness skin graft has favorable vascular characteristics but tends to contract. The full-thickness skin graft tends to have more fastidious vascular characteristics, but there is less contraction. There is a difference between genital full-thickness skin (penile and preputial skin grafts) and most areas of extragenital full-thickness skin. This is probably a reflection of the increased mass of the graft
256 Practical Urology: EssEntial PrinciPlEs and PracticE
|
|
|
1.5:1, 2:1, 3:1). For most genital reconstructive |
|
|
|
|
|
|
|
surgery, these slits are useful to allow subgraft |
|
|
|
collections to escape, and the slits allow the graft |
|
|
|
to conform better to irregular graft host beds |
|
|
|
(e.g., the testes in split-thickness skin graft scro- |
|
|
|
tal reconstruction). |
|
|
|
The posterior auricular graft, or Wolff graft, is |
|
|
|
an exception to the rule concerning extragenital |
FTSG |
|
|
skin. This skin is thin and overlies the tempora- |
|
|
|
lis fascia and thought to be carried on numerous |
|
|
|
perforators. The subdermal plexus of this graft |
|
|
|
thus mimics the characteristics of the intrader- |
|
|
|
mal plexus, and the total mass of the graft is |
|
|
|
more like that of the split-thickness unit. In the |
|
|
|
bladder epithelial graft (Fig. 19.2), there is a |
|
|
|
superficial and a deep plexus; however, the plex- |
|
|
|
uses are connected by many more perforators |
|
|
|
and the sublaminar lexus is composed of plenti- |
|
|
|
|
|
|
|
ful vessels. Thus, bladder epithelial grafts tend |
|
|
|
to have more favorable vascular characteristics, |
|
|
|
and as units are very thin.18 |
Figure 19.6. cross-section of anatomy of the skin with the level |
There is a panlaminar plexus in oral mucosa, |
||
of a full-thickness skin graft demonstrated (reprinted with per- |
allowing it to be thinned, provided a sufficient |
||
mission from Jordan and schlossberg17. contemporary Urology |
amount of deep lamina is carried to preserve the |
||
is a copyrighted publication of advanstar communications inc. |
physical characteristics (Fig. 19.3). The oral/ |
||
all rights reserved). |
buccal mucosal graft is thought to have optimal |
||
|
|
|
|
|
|
|
vascular characteristics. The thinned graft |
in extragenital skin grafts. This increased mass |
diminishes the total graft mass while preserving |
||
makes imbibition more tenuous, and the poor |
the physical characteristics and not adversely |
||
results reported with urethral reconstruction |
affecting the vascular characteristics. The “wet |
||
with extragenital full-thickness skin grafts are |
epithelial” surface of buccal mucosa is also |
||
likely a result of poor take.18 |
thought to be a favorable property for many |
||
The mesh graft is usually an application of |
cases of urethral reconstructive surgery. |
||
the split-thickness graft. After the harvest of a |
The dermal graft has been used for years to |
||
sheet graft, the sheet is placed on a carrier that |
augment the tunica albuginea of the corpora |
||
cuts systematically placed slits in the graft.These |
cavernosa. When it is harvested, the graft |
||
slits can expand the graft by various ratios (i.e., |
exposes both the intradermal plexus and the |
Intradermal plexus
Subdermal plexus
Figure 19.7. cross-section anatomy of the vascularity of the skin.
257
WoUnd HEaling and PrinciPlEs of Plastic sUrgEry
deep dermal plexus. The dermal graft thus takes |
tissue engineering are incorrectly termed grafts. |
||
readily and has the physical characteristics of |
The precise mechanism by which these collagen |
||
normal skin. Dermal grafts have been used in |
matrices are handled by the body and incorpo- |
||
urethral reconstruction, albeit with poor results. |
rated with living tissues are poorly defined. Any |
||
When prepared properly, the tunica vaginalis |
of the “off-the-shelf grafts” used for urologic |
||
graft is essentially peritoneum. Tunica vaginalis |
surgery are essentially an acellular collagen |
||
grafts have been shown to be useful for repair of |
matrix. The future of graft materials seems to lie |
||
small defects of the tunica albuginea of the cor- |
in the field of tissue engineering. Both urothe- |
||
pora cavernosa, but in larger grafts there is a |
lium and buccal mucosa have been cultured suc- |
||
tendency to aneurysmal dilation. Tunica vagina- |
cessfully. However, there is no long-term data to |
||
lis grafts have been tried in urethral reconstruc- |
follow the success of these patients, and with |
||
tion with uniformly poor results. |
|
many aspects of tissue engineering, the problem |
|
As an alternative to dermal grafts, the vein |
is not with the culture of tissues but rather with |
||
graft has been used with some success. Initially it |
the correct choice and use of carrier. |
||
was felt that vein grafts did not really take but |
|
||
rather,became directly vascularized.In fact,these |
|
||
grafts seem to take in a similar process as already |
Flap |
||
described. When it is placed under pressure the |
|||
Tissue can also be transferred as a flap. The term |
|||
wall tends to thicken, which has also been called |
|||
“arterialization.” Arterialization |
is associated |
flap refers to tissue that is excised and trans- |
|
with changes in the elastic properties of the ves- |
ferred with the blood supply either preserved, |
||
sel wall, and the graft becomes rigid with low |
or surgically reestablished, at the recipient site. |
||
compliance.Vein grafts are currently being widely |
There is some confusion with respect to the ter- |
||
used for replacement of defects of the tunica |
minology of tissue transfer. Many use the term |
||
albuginea of the corpora cavernosa, in some cen- |
graft to refer to any tissue that is transferred. |
||
ters. Rectal mucosal grafts have been proposed |
However, the term graft implies a specific unit of |
||
for urethral reconstruction. In general, the vascu- |
transfer, and using terms such as pedicle graft or |
||
larity of the bowel mucosa is based on the vascu- |
free graft are confusing. It is best to avoid these |
||
larity of the underlying muscle, with the mucosa |
terms in discussing tissue transfer. |
||
carried on perforators. Little is found in the liter- |
Flaps can be classified by a number of crite- |
||
ature regarding the process of take of these grafts; |
ria. Flaps are often classified based on their vas- |
||
however, it can be presumed to be identical to the |
cularity and we can thus describe flaps as either |
||
processes already described. |
|
random flaps or axial flaps (Fig. 19.8). A ran- |
|
The acellular collagen matrices that have been |
dom flap is a flap without a defined and repro- |
||
more commonly used with the |
advances in |
ducible cuticular vascular territory. The flap is |
Figure 19.8. demonstration of flaps based on their vascularity. in the case of a random flap, the flap is elevated on the intradermal and subdermal plexuses.there is no defined artery in the base of the flap (reprinted with permission from Jordan and schlossberg17. contemporary Urology is a copyrighted publication of advanstar communications inc. all rights reserved).
258
Practical Urology: EssEntial PrinciPlEs and PracticE
Figure 19.9. axial flap, there is a defined artery in the base of the flap. demonstrated are (a) axial peninsula flap, (b) axial island flap, (c) axial microvascular free transfer flap (reprinted with permission from Jordan and Mccraw15. copyright © american Urological association Education and research, inc).
Figure 19.10. (a) demonstration of the musculocutaneous system flap vascularity (reprinted with permission from Jordan and Mccraw15. copyright © american Urological association Education and research, inc) (b) demonstration of the fasciocutaneous system of vascularity (reprinted with permission from Jordan and schlossberg17. contemporary Urology is a copyrighted publication of advanstar communications inc. all rights reserved).
a
b
Figure 19.11. demonstration of the difference between an axial island flap and a skin island or paddle carried on a flap: (a) true island flap, (b) demonstration of a skin island carried on a fascial flap.
carried on the dermal or laminar plexuses; the dimensions of random flaps can vary widely depending on the individual and the flap donor site. The term axial flap refers to the presence of a defined vessel in the base of the flap (Fig. 19.9). There are three types of axial flaps. The direct cuticular axial flap is a flap based on a vessel superficial to the superficial layer of the deep body wall fascia. The classic example of a direct cuticular flap is the groin flap. A musculocutaneous flap (Fig. 19.10), on the other hand, is based on the vascular supply to the muscle. The overlying skin paddle is carried on perforators. If the muscle alone is carried as a flap, the overlying skin survives as a random unit. The fasciocutaneous flap has a similar vascular pattern to the musculocutaneous system. However, the deep blood supply is carried on the fascia (both deep and superficial layers), and the overlying skin paddle is based again on perforators. Familiar to most urologists are the local genital flaps used for hypospadias or other urethral reconstruction. Thus, one can transfer a fascial flap based on the deep blood supply associated with the flap. It has been argued that fascia is relatively avascular and hence cannot serve as “the blood supply” to the fasciocutaneous unit. In reality, the fascia acts as a trellis and the vessels are carried much like the limbs of a vine.15
Flaps can also be classified by elevation technique. A peninsular flap is a flap in which the vascular supply and the skin of the flap base are left intact. An island flap is a flap in which the skin is divided but the vessels are left intact